在Q1损失和利润预测减少之后,Integra LifeSciences的股票下跌25%。 Integra LifeSciences' stock plunges 25% after Q1 loss and reduced profit forecasts.

Integra Life Sciences在报告Q1净损失2 530万美元(比去年的330万美元增加)后,其库存下降了近25%,降至12.78美元。 Integra LifeSciences saw its stock drop by nearly 25% to $12.78 after reporting a Q1 net loss of $25.3 million, up from $3.3 million last year. 尽管收入略微增加到3.827亿美元,但该公司因关税影响调整了EPS准则。 Despite a slight revenue increase to $382.7 million, the company adjusted its EPS guidance due to tariff impacts. Integra重申其2025年的收入预测,但由于质量问题和关键领域销售缓慢,利润预期减少。 Integra reaffirmed its 2025 revenue forecast but reduced profit expectations due to quality issues and slower sales in key areas. 股份波动很大,去年有21次移动超过5%。 Shares have been volatile, with 21 moves over 5% in the past year.